Trials / Unknown
UnknownNCT06344936
Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects
Open-Label Assessment of the Effects of Itraconazole and Rifampicin on HRS-1780 Pharmacokinetics in Healthy Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study was designed to evaluate the pharmacokinetic effects of itraconazole and rifampicin on HRS-1780 after oral administration of HRS-1780 tablets in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1780 tablets; Itraconazole capsules; Rifampicin capsules | Treatment PartⅠ: Itraconazole capsule, 200mg QD, 7 times; HRS-1780 tablets, 10mg QD, twice Treatment PartⅡ: Rifampicin capsules, 600mg QD, 14 times; HRS-1780 tablets, 10mg QD, twice |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2024-04-03
- Last updated
- 2024-04-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06344936. Inclusion in this directory is not an endorsement.